FTSE 100
|
9 870,68
|
-18,54
|
-0,19 %
|
Analysen zu FTSE 100-Werten
| 09.04.24 | Diageo Hold | Jefferies & Company Inc. | |
| 09.04.24 | BP Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 08.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.04.24 | Unilever Overweight | Barclays Capital | |
| 05.04.24 | Shell Overweight | Barclays Capital | |
| 05.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 05.04.24 | National Grid Buy | UBS AG | |
| 05.04.24 | Shell Neutral | UBS AG | |
| 05.04.24 | Shell Outperform | RBC Capital Markets | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell Buy | Jefferies & Company Inc. | |
| 05.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | GSK Equal Weight | Barclays Capital | |
| 04.04.24 | Rio Tinto Overweight | Barclays Capital | |
| 04.04.24 | International Consolidated Airlines Outperform | Bernstein Research | |
| 04.04.24 | BP Buy | UBS AG | |
| 04.04.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 04.04.24 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 04.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | BP Outperform | RBC Capital Markets | |
| 04.04.24 | Shell Outperform | RBC Capital Markets | |
| 03.04.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.24 | Shell Buy | Jefferies & Company Inc. | |
| 03.04.24 | BP Buy | Jefferies & Company Inc. | |
| 03.04.24 | Vodafone Group Underperform | Bernstein Research | |
| 02.04.24 | Unilever Overweight | Barclays Capital | |
| 02.04.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 02.04.24 | Barclays Buy | Jefferies & Company Inc. | |
| 02.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 28.03.24 | easyJet Overweight | JP Morgan Chase & Co. | |
| 28.03.24 | Shell Outperform | RBC Capital Markets | |
| 28.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 28.03.24 | Reckitt Benckiser Buy | UBS AG | |
| 28.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 28.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.